Platelet function and coagulation abnormalities in type 1 Gaucher disease patients: Effects of enzyme replacement therapy (ERT) [2]

Journal of Thrombosis and Haemostasis

Volumn 4, Issue 8, 2006, Pages 1831-1833

  Giona, Fiorina ^a   Palumbo, G ^a   Amendola, A ^a   Santoro, C ^a   Mazzuconi, M G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALGLUCERASE; FIBRINOGEN; GLUCOSYLCERAMIDE; IMIGLUCERASE;

ADULT; BLEEDING TIME; BLOOD CLOTTING DISORDER; BLOOD CLOTTING FACTOR DEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; HUMAN; LABORATORY TEST; LETTER; LOW DRUG DOSE; MALE; NORMAL VALUE; PARTIAL THROMBOPLASTIN TIME; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTHROMBIN TIME; REFERENCE VALUE; SCHOOL CHILD; SPLEEN SIZE; SPLENECTOMY; SYMPTOM; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT; THROMBOCYTE FUNCTION; TREATMENT DURATION; TREATMENT OUTCOME;

ADOLESCENT; ADULT; BLOOD COAGULATION; BLOOD PLATELETS; CHILD; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GAUCHER DISEASE; GLUCOSYLCERAMIDASE; HEMOSTASIS; HUMANS; MALE; MIDDLE AGED; PLATELET FUNCTION TESTS;

EID: 33746638717     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02037.x     Document Type: Letter

References (9)

1. Berrebi A, Malnick S, Vorst E, Stein D. High incidence of factor XI deficiency in Gaucher's disease. Am J Hematol 1992; 40: 153-61.
2. Gillis S, Hyam E, Abrahamov A, Elstein D, Zimran A. Platelet function abnormalities in Gaucher disease patients. Am J Hematol 1999; 61: 103-6.
3. Kelsey H, Christopoulos C, Gray A, Machin S. Acquired pseudo-pseudo Bernard-Soulier syndrome complicating Gaucher's disease. J Clin Pathol 1994; 47: 162-5.
4. Billett HH, Rizvi S, Sawitsky A. Coagulation abnormalities in patients with Gaucher's disease: Effect of therapy. Am J Hematol 1996; 51: 234-6.
5. Hollack CEM, Levi M, Berends F, Aerts JMFG, Van Oers MHJ. Coagulation abnormalities in type I Gaucher disease a re due to low-grade activation and can be partly restored by enzyme supplementation therapy. Br J Haematol 1997; 96: 470-6.
6. Humphries J, Hess C. Gaucher's disease and acquired coagulopathy. Am J Hematol 1994; 45: 347-8.
7. Barone R, Giuffrida G, Musso R, Carpinteri G, Fiumara A. Haemostatic abnormalities and lupus anticoagulant activity in patients with Gaucher disease type I. J Inherit Metab Dis 2000; 23: 387-90.
8. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force. Guidelines on platelet function testing. J Clin Pathol 1988; 41: 1322-30.
9. Sawitsky A, Boklan B. Gaucher's disease and coagulation factors. Ann Intern Med 1972; 77: 150-1.